Inhibition of the BMP Signaling Pathway Ameliorated Established Clinical Symptoms of Experimental Autoimmune Encephalomyelitis

Herena Eixarch(Universitat Autònoma de Barcelona), Carmen Espejo(Universitat Autònoma de Barcelona)

Neurotherapeutics

July 17, 2020

10.1007/s13311-020-00885-8

Cited by 12

Related Papers

The value of oligoclonal bands in the multiple sclerosis diagnostic criteria

|Brain|2018|158

NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients

|Brain|2020|136

Neurofilament light chain level is a weak risk factor for the development of MS

|Neurology|2016|108

Combined therapies to treat complex diseases: The role of the gut microbiota in multiple sclerosis

|Autoimmunity Reviews|2017|95

Immunosenescence in multiple sclerosis: the identification of new therapeutic targets

|Autoimmunity Reviews|2021|94